Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | TAR DNA binding protein | Starlite/ChEMBL | No references |
Homo sapiens | glucagon-like peptide 1 receptor | Starlite/ChEMBL | No references |
Homo sapiens | SMAD family member 2 | Starlite/ChEMBL | No references |
Homo sapiens | glycoprotein hormones, alpha polypeptide | Starlite/ChEMBL | No references |
Homo sapiens | ataxin 2 | Starlite/ChEMBL | No references |
Homo sapiens | polo-like kinase 1 | Starlite/ChEMBL | No references |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Toxoplasma gondii | intraflagellar transport protein 172, putative | glycoprotein hormones, alpha polypeptide | 116 aa | 94 aa | 26.6 % |
Brugia malayi | MH2 domain containing protein | SMAD family member 2 | 467 aa | 405 aa | 31.6 % |
Loa Loa (eye worm) | pigment dispersing factor receptor c | glucagon-like peptide 1 receptor | 463 aa | 388 aa | 25.8 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Schistosoma mansoni | tar DNA-binding protein | 0.0076 | 0.4565 | 0.4847 |
Trichomonas vaginalis | CAMK family protein kinase | 0.0114 | 0.7583 | 1 |
Schistosoma mansoni | serine/threonine protein kinase | 0.0114 | 0.7583 | 1 |
Onchocerca volvulus | Serine\/threonine kinase homolog | 0.0114 | 0.7583 | 0.5 |
Schistosoma mansoni | tar DNA-binding protein | 0.0076 | 0.4565 | 0.4847 |
Plasmodium falciparum | ataxin-2 like protein, putative | 0.003 | 0.0866 | 0.5 |
Schistosoma mansoni | tar DNA-binding protein | 0.0076 | 0.4565 | 0.4847 |
Loa Loa (eye worm) | TAR-binding protein | 0.0076 | 0.4565 | 0.405 |
Plasmodium vivax | ataxin-2 like protein, putative | 0.003 | 0.0866 | 0.5 |
Brugia malayi | RNA recognition motif domain containing protein | 0.0076 | 0.4565 | 0.4565 |
Trichomonas vaginalis | CAMK family protein kinase | 0.0114 | 0.7583 | 1 |
Schistosoma mansoni | tar DNA-binding protein | 0.0076 | 0.4565 | 0.4847 |
Trypanosoma brucei | polo-like protein kinase | 0.0114 | 0.7583 | 1 |
Giardia lamblia | Kinase, PLK | 0.0114 | 0.7583 | 0.5 |
Loa Loa (eye worm) | PLK/PLK1 protein kinase | 0.0114 | 0.7583 | 0.7353 |
Loa Loa (eye worm) | MH2 domain-containing protein | 0.0144 | 1 | 1 |
Loa Loa (eye worm) | pigment dispersing factor receptor c | 0.006 | 0.3256 | 0.2617 |
Trichomonas vaginalis | CAMK family protein kinase | 0.0114 | 0.7583 | 1 |
Entamoeba histolytica | serine/threonine protein kinase, putative | 0.0114 | 0.7583 | 0.5 |
Trichomonas vaginalis | CAMK family protein kinase | 0.0114 | 0.7583 | 1 |
Plasmodium falciparum | ataxin-2 like protein, putative | 0.003 | 0.0866 | 0.5 |
Loa Loa (eye worm) | RNA recognition domain-containing protein domain-containing protein | 0.0076 | 0.4565 | 0.405 |
Brugia malayi | hypothetical protein | 0.003 | 0.0866 | 0.0866 |
Loa Loa (eye worm) | hypothetical protein | 0.006 | 0.3256 | 0.2617 |
Brugia malayi | serine/threonine-protein kinase plk-2 | 0.0114 | 0.7583 | 0.7583 |
Trichomonas vaginalis | CAMK family protein kinase | 0.0114 | 0.7583 | 1 |
Brugia malayi | latrophilin 2 splice variant baaae | 0.0041 | 0.1727 | 0.1727 |
Loa Loa (eye worm) | transcription factor SMAD2 | 0.0144 | 1 | 1 |
Schistosoma mansoni | kinase | 0.0058 | 0.3078 | 0.2307 |
Echinococcus multilocularis | serine:threonine protein kinase PLK1 | 0.0114 | 0.7583 | 1 |
Trichomonas vaginalis | CAMK family protein kinase | 0.0114 | 0.7583 | 1 |
Trypanosoma cruzi | polo-like protein kinase, putative | 0.0114 | 0.7583 | 1 |
Brugia malayi | TAR-binding protein | 0.0076 | 0.4565 | 0.4565 |
Loa Loa (eye worm) | hypothetical protein | 0.0041 | 0.1727 | 0.0942 |
Trypanosoma cruzi | polo-like protein kinase, putative | 0.0114 | 0.7583 | 1 |
Brugia malayi | Calcitonin receptor-like protein seb-1 | 0.006 | 0.3256 | 0.3256 |
Echinococcus granulosus | serine:threonine protein kinase PLK1 | 0.0114 | 0.7583 | 1 |
Brugia malayi | Corticotropin releasing factor receptor 2 precursor, putative | 0.006 | 0.3256 | 0.3256 |
Trichomonas vaginalis | CAMK family protein kinase | 0.0114 | 0.7583 | 1 |
Toxoplasma gondii | LsmAD domain-containing protein | 0.003 | 0.0866 | 0.5 |
Loa Loa (eye worm) | RNA binding protein | 0.0076 | 0.4565 | 0.405 |
Leishmania major | protein kinase, putative,polo-like protein kinase, putative | 0.0114 | 0.7583 | 1 |
Brugia malayi | RNA binding protein | 0.0076 | 0.4565 | 0.4565 |
Schistosoma mansoni | tar DNA-binding protein | 0.0076 | 0.4565 | 0.4847 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Potency (functional) | 5.0119 uM | PubChem BioAssay. qHTS of TDP-43 Inhibitors. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 7.5193 uM | PubChem BioAssay. qHTS for Inhibitors of PLK1-PDB (polo-like kinase 1 - polo-box domain): Primary Screen. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 7.9433 uM | PubChem BioAssay. qHTS for Inhibitors of ATXN expression. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 10 uM | PubChem BioAssay. qHTS of GLP-1 Receptor Inverse Agonists (Inhibition Mode). (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 10 uM | PubChem BioAssay. qHTS for Activators of Integrin-Mediated Alleviation for Muscular Dystrophy. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 12.5893 uM | PUBCHEM_BIOASSAY: qHTS for Inhibitors of TGF-b: Cytotox Counterscreen. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588855, AID588860] | ChEMBL. | No reference |
Potency (functional) | 14.1254 uM | PUBCHEM_BIOASSAY: qHTS for Inhibitors of TGF-b. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588856, AID588860] | ChEMBL. | No reference |
Potency (functional) | 29.0929 uM | PubChem BioAssay. qHTS for induction of synthetic lethality in tumor cells producing 2HG: qHTS for the HT-1080-NT fibrosarcoma cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 31.6228 uM | PubChem BioAssay. qHTS for Inhibitors of Vif-A3G Interactions: qHTS. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 35.4813 uM | PubChem BioAssay. qHTS for Agonist of gsp, the Etiologic Mutation Responsible for Fibrous Dysplasia/McCune-Albright Syndrome: qHTS. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 35.4813 uM | PubChem BioAssay. qHTS of alpha-syn Inhibitors. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 39.8107 uM | PubChem BioAssay. qHTS of PTHR Inhibitors: Primary Screen. (Class of assay: confirmatory) | ChEMBL. | No reference |
Species name | Source | Reference | Is orphan |
---|---|---|---|
Homo sapiens | ChEMBL23 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.